Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 52

1.

MicroRNAs and acute myeloid leukemia: therapeutic implications and emerging concepts.

Wallace JA, O'Connell RM.

Blood. 2017 Sep 14;130(11):1290-1301. doi: 10.1182/blood-2016-10-697698. Epub 2017 Jul 27. Review.

PMID:
28751524
2.

Specific Depletion of Leukemic Stem Cells: Can MicroRNAs Make the Difference?

Martiáñez Canales T, de Leeuw DC, Vermue E, Ossenkoppele GJ, Smit L.

Cancers (Basel). 2017 Jun 30;9(7). pii: E74. doi: 10.3390/cancers9070074. Review.

3.

Axonal microRNAs: localization, function and regulatory mechanism during axon development.

Wang B, Bao L.

J Mol Cell Biol. 2017 Apr 1;9(2):82-90. doi: 10.1093/jmcb/mjw050. Review.

4.

Regulatory landscape and clinical implication of MBD3 in human malignant glioma.

Cui Y, Li J, Weng L, Wirbisky SE, Freeman JL, Liu J, Liu Q, Yuan X, Irudayaraj J.

Oncotarget. 2016 Dec 6;7(49):81698-81714. doi: 10.18632/oncotarget.13173.

5.

Upregulation of miR-99a is associated with poor prognosis of acute myeloid leukemia and promotes myeloid leukemia cell expansion.

Si X, Zhang X, Hao X, Li Y, Chen Z, Ding Y, Shi H, Bai J, Gao Y, Cheng T, Yang FC, Zhou Y.

Oncotarget. 2016 Nov 22;7(47):78095-78109. doi: 10.18632/oncotarget.12947.

6.

MicroRNA-106b~25 cluster is upregulated in relapsed MLL-rearranged pediatric acute myeloid leukemia.

Verboon LJ, Obulkasim A, de Rooij JD, Katsman-Kuipers JE, Sonneveld E, Baruchel A, Trka J, Reinhardt D, Pieters R, Cloos J, Kaspers GJ, Klusmann JH, Zwaan CM, Fornerod M, van den Heuvel-Eibrink MM.

Oncotarget. 2016 Jul 26;7(30):48412-48422. doi: 10.18632/oncotarget.10270.

7.

The miR-17∼92 cluster contributes to MLL leukemia through the repression of MEIS1 competitor PKNOX1.

Mian YA, Zeleznik-Le NJ.

Leuk Res. 2016 Jul;46:51-60. doi: 10.1016/j.leukres.2016.04.006. Epub 2016 Apr 16.

8.

Identification of MLL-fusion/MYC⊣miR-26⊣TET1 signaling circuit in MLL-rearranged leukemia.

Huang H, Jiang X, Wang J, Li Y, Song CX, Chen P, Li S, Gurbuxani S, Arnovitz S, Wang Y, Weng H, Neilly MB, He C, Li Z, Chen J.

Cancer Lett. 2016 Mar 28;372(2):157-65. doi: 10.1016/j.canlet.2015.12.032. Epub 2016 Jan 11.

9.

The regulatory and predictive functions of miR-17 and miR-92 families on cisplatin resistance of non-small cell lung cancer.

Zhao J, Fu W, Liao H, Dai L, Jiang Z, Pan Y, Huang H, Mo Y, Li S, Yang G, Yin J.

BMC Cancer. 2015 Oct 19;15:731. doi: 10.1186/s12885-015-1713-z.

10.

The MYC/miR-17-92 axis in lymphoproliferative disorders: A common pathway with therapeutic potential.

Dal Bo M, Bomben R, Hernández L, Gattei V.

Oncotarget. 2015 Aug 14;6(23):19381-92. Review.

11.

Cooperative target mRNA destabilization and translation inhibition by miR-58 microRNA family in C. elegans.

Subasic D, Brümmer A, Wu Y, Pinto SM, Imig J, Keller M, Jovanovic M, Lightfoot HL, Nasso S, Goetze S, Brunner E, Hall J, Aebersold R, Zavolan M, Hengartner MO.

Genome Res. 2015 Nov;25(11):1680-91. doi: 10.1101/gr.183160.114. Epub 2015 Jul 31.

12.

An allelic series of miR-17 ∼ 92-mutant mice uncovers functional specialization and cooperation among members of a microRNA polycistron.

Han YC, Vidigal JA, Mu P, Yao E, Singh I, González AJ, Concepcion CP, Bonetti C, Ogrodowski P, Carver B, Selleri L, Betel D, Leslie C, Ventura A.

Nat Genet. 2015 Jul;47(7):766-75. doi: 10.1038/ng.3321. Epub 2015 Jun 1.

13.

WEE1 is a validated target of the microRNA miR-17-92 cluster in leukemia.

Brockway S, Zeleznik-Le NJ.

Cancer Genet. 2015 May;208(5):279-87. doi: 10.1016/j.cancergen.2015.01.001. Epub 2015 Jan 20.

14.

Novel agent nitidine chloride induces erythroid differentiation and apoptosis in CML cells through c-Myc-miRNAs axis.

Liu N, Li P, Zang S, Liu Q, Ma D, Sun X, Ji C.

PLoS One. 2015 Feb 3;10(2):e0116880. doi: 10.1371/journal.pone.0116880. eCollection 2015.

15.

miR-17 deregulates a core RUNX1-miRNA mechanism of CBF acute myeloid leukemia.

Fischer J, Rossetti S, Datta A, Eng K, Beghini A, Sacchi N.

Mol Cancer. 2015 Jan 23;14:7. doi: 10.1186/s12943-014-0283-z.

16.

Limited miR-17-92 overexpression drives hematologic malignancies.

Danielson LS, Reavie L, Coussens M, Davalos V, Castillo-Martin M, Guijarro MV, Coffre M, Cordon-Cardo C, Aifantis I, Ibrahim S, Liu C, Koralov SB, Hernando E.

Leuk Res. 2015 Mar;39(3):335-41. doi: 10.1016/j.leukres.2014.12.002. Epub 2014 Dec 10.

17.
18.

Integrated Analysis of Dysregulated miRNA-gene Expression in HMGA2-silenced Retinoblastoma Cells.

Venkatesan N, Deepa P, Vasudevan M, Khetan V, Reddy AM, Krishnakumar S.

Bioinform Biol Insights. 2014 Sep 4;8:177-91. doi: 10.4137/BBI.S16958. eCollection 2014.

19.

miR-17 extends mouse lifespan by inhibiting senescence signaling mediated by MKP7.

Du WW, Yang W, Fang L, Xuan J, Li H, Khorshidi A, Gupta S, Li X, Yang BB.

Cell Death Dis. 2014 Jul 31;5:e1355. doi: 10.1038/cddis.2014.305.

20.

Genomic characterization of acute leukemias.

Chiaretti S, Gianfelici V, Ceglie G, Foà R.

Med Princ Pract. 2014;23(6):487-506. doi: 10.1159/000362793. Epub 2014 Jun 20. Review.

Supplemental Content

Support Center